CD44 and prostate carcinoma: Interestingly, 100% of prostatic small cell NE carcinomas, an aggressive variant of prostate cancer that is composed of highly proliferating NE cells, have CD44 expression, whereas its expression was detectable only in a minority of small cell NE carcinoma from other organs.